Submit Deal

Announced

2 Aug 2022

Completed

2 Aug 2022

Abu Dhabi Investment Authority and GIC led a $300m funding round in Taibang Biologic.

Synopsis

Sovereign wealth funds Abu Dhabi Investment Authority and GIC led a $300m funding round in Taibang Biologic, a biopharmaceutical firm. The proceeds will be used to finance its expansion of plasma stations and its research and development of new products.

Principals

target

Taibang Biologic

bidder

Gic Private

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (6)

kelli rivers

Associate at Davis Polk & Wardwell

Lawyer

target

Deals

£ 14.52 B

Total Value

alon gurfinkel

Counsel at Davis Polk & Wardwell

Lawyer

target

Deals

£ 31.21 B

Total Value

yang chu

Partner at Davis Polk & Wardwell

Lawyer

target

Deals

£ 3.68 B

Total Value

jie zhang

Associate at Davis Polk & Wardwell

Lawyer

target

Deals

£ 16.11 B

Total Value

howard zhang

Partner at Davis Polk & Wardwell

Lawyer

target

Deals

£ 20.55 B

Total Value

jennifer ng

Associate at Davis Polk & Wardwell

Lawyer

target

Deal

£ 245 M

Total Value

Bidder Team (6)

lim chow kiat

CEO at GIC PRIVATE LIMITED

Investor

bidder

181

Deals

£ 236.94 B

Total Value

yuiyee wong

Associate at White & Case

Lawyer

bidder

Deals

£ 1.80 B

Total Value

steven sha

Partner at White & Case

Lawyer

bidder

Deals

£ 4.70 B

Total Value

jingbo hou

Paralegal at White & Case

Lawyer

bidder

Deals

£ 2.67 B

Total Value

david li

Partner at White & Case

Lawyer

bidder

Deals

£ 578 M

Total Value

daniel abercromby

Partner at White & Case

Lawyer

bidder

Deals

£ 13.71 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy